Previous 10 | Next 10 |
Royalty Pharma plc (RPRX) Q1 2021 Earnings Conference Call May 11, 2021 08:00 ET Company Participants George Grofik - Senior Vice President and Head, Investor Relations and Communications Pablo Legorreta - Founder and Chief Executive Officer Marshall Urist - Executive Vice President and Co-He...
Double-digit growth in Net cash provided by operating activities (GAAP) and Adjusted Cash Flow ( 2) Announced transactions of up to $787 million in 2021, including $582 million in upfront payments Increased Adjusted Cash Receipts ( 1) guidance for 202...
Kyowa Kirin (KYKOF) announced that the European Medicines Agency ((EMA)) has recommended the self-administration option of CRYSVITA (burosumab) for the treatment of X-linked hypophosphataemia ((XLH)).The decision by the Committee for Medicinal Products for Human Use ((CHMP)) of EMA ...
GlaxoSmithKline (NYSE: GSK) announced plans to sell the royalties it receives on sales of Exelixis ' (NASDAQ: EXEL) Cabometyx and Cometriq to Royalty Pharma (NASDAQ: RPRX) . In this video from Motley Fool Live , recorded on April 5 , Fool.com Contribu...
NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: Bank of America 2021 Healthcare Conference on Wednesday, May 12 at 9:30 a.m. EDT 7 th ...
Royalty Pharma is a new type of healthcare company. They buy up royalties from other biopharma and have many blockbusters in their portfolio. They pay a small dividend, which, if it increases over the years, maybe a good thing. For further details see: Royalty Pharma: A ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Earnings reports will dominate the action next week even as investors keep a watch for any developments with an infrastr...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2021 financial results on Tuesday, May 11, 2021 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:...
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced a collaboration with MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, to expand MSCI’s thematic index suite wi...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experie...
2024-07-24 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...